Capital Research Global Investors Abbott Laboratories Transaction History

Capital Research Global Investors

  • $466 Billion
  • Q4 2024

A detailed history of Capital Research Global Investors transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Research Global Investors holds 54,097,005 shares of ABT stock, worth $7.18 Billion. This represents 1.31% of its overall portfolio holdings.

Number of Shares
54,097,005
Previous 53,301,932 1.49%
Holding current value
$7.18 Billion
Previous $6.08 Billion 0.69%
% of portfolio
1.31%
Previous 1.31%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$111.93 - $119.39 $89 Million - $94.9 Million
795,073 Added 1.49%
54,097,005 $6.12 Billion
Q3 2024

Nov 13, 2024
SELL
$100.07 - $118.13 $394 Million - $465 Million
-3,935,660 Reduced 6.88%
53,301,932 $6.08 Billion
Q2 2024

Aug 13, 2024
SELL
$100.73 - $112.44 $2.69 Billion - $3.01 Billion
-26,747,139 Reduced 31.85%
57,237,592 $5.95 Billion
Q1 2024

May 14, 2024
SELL
$109.52 - $120.96 $285 Million - $315 Million
-2,603,883 Reduced 3.01%
83,984,731 $9.55 Billion
Q4 2023

Feb 13, 2024
BUY
$90.19 - $110.4 $679 Million - $831 Million
7,527,778 Added 9.52%
86,588,614 $9.53 Billion
Q3 2023

Nov 13, 2023
BUY
$95.53 - $114.62 $175 Million - $210 Million
1,835,578 Added 2.38%
79,060,836 $7.66 Billion
Q2 2023

Aug 11, 2023
BUY
$100.78 - $112.29 $82.7 Million - $92.1 Million
820,369 Added 1.07%
77,225,258 $8.42 Billion
Q1 2023

May 15, 2023
SELL
$96.86 - $114.01 $36.9 Million - $43.4 Million
-380,473 Reduced 0.5%
76,404,889 $7.74 Billion
Q4 2022

Feb 14, 2023
SELL
$95.06 - $111.52 $192 Million - $225 Million
-2,021,452 Reduced 2.57%
76,785,362 $8.43 Billion
Q3 2022

Nov 14, 2022
SELL
$96.76 - $112.03 $125 Million - $145 Million
-1,290,514 Reduced 1.61%
78,806,814 $7.63 Billion
Q2 2022

Aug 15, 2022
SELL
$102.07 - $123.37 $59.2 Million - $71.6 Million
-580,262 Reduced 0.72%
80,097,328 $8.7 Billion
Q1 2022

May 16, 2022
SELL
$114.02 - $139.04 $393 Million - $479 Million
-3,447,439 Reduced 4.1%
80,677,590 $9.55 Billion
Q4 2021

Feb 14, 2022
SELL
$115.53 - $141.46 $37.9 Million - $46.4 Million
-327,768 Reduced 0.39%
84,125,029 $11.8 Billion
Q3 2021

Nov 15, 2021
SELL
$116.66 - $129.06 $160 Million - $177 Million
-1,368,008 Reduced 1.59%
84,452,797 $9.98 Billion
Q2 2021

Aug 16, 2021
BUY
$105.79 - $124.53 $3.12 Million - $3.68 Million
29,539 Added 0.03%
85,820,805 $9.95 Billion
Q1 2021

May 14, 2021
SELL
$108.84 - $128.23 $65.6 Million - $77.3 Million
-602,933 Reduced 0.7%
85,791,266 $10.3 Billion
Q4 2020

Feb 12, 2021
SELL
$105.0 - $114.42 $107 Million - $117 Million
-1,019,461 Reduced 1.17%
86,394,199 $9.46 Billion
Q3 2020

Nov 13, 2020
SELL
$91.64 - $111.29 $373,341 - $453,395
-4,074 Reduced -0.0%
87,413,660 $9.51 Billion
Q2 2020

Aug 14, 2020
SELL
$76.57 - $98.0 $647 Million - $828 Million
-8,450,164 Reduced 8.81%
87,417,734 $7.99 Billion
Q1 2020

May 15, 2020
SELL
$62.82 - $91.86 $1.12 Billion - $1.64 Billion
-17,821,395 Reduced 15.68%
95,867,898 $7.56 Billion
Q4 2019

Feb 18, 2020
BUY
$78.51 - $87.4 $48.4 Million - $53.9 Million
616,255 Added 0.55%
113,689,293 $9.88 Billion
Q3 2019

Nov 14, 2019
SELL
$81.84 - $88.74 $304 Million - $330 Million
-3,716,315 Reduced 3.18%
113,073,038 $9.46 Billion
Q2 2019

Aug 14, 2019
BUY
$72.88 - $85.0 $88.8 Million - $104 Million
1,217,776 Added 1.05%
116,789,353 $9.82 Billion
Q1 2019

May 15, 2019
SELL
$66.22 - $80.06 $421 Million - $509 Million
-6,356,769 Reduced 5.21%
115,571,577 $9.24 Billion
Q4 2018

Feb 14, 2019
SELL
$65.56 - $74.27 $213 Million - $241 Million
-3,241,452 Reduced 2.59%
121,928,346 $8.82 Billion
Q3 2018

Nov 14, 2018
SELL
$60.81 - $73.36 $361 Million - $435 Million
-5,929,990 Reduced 4.52%
125,169,798 $9.18 Billion
Q2 2018

Aug 14, 2018
BUY
$57.57 - $63.54 $1.04 Billion - $1.14 Billion
18,000,566 Added 15.92%
131,099,788 $8 Billion
Q1 2018

May 15, 2018
BUY
$56.27 - $63.62 $1.57 Billion - $1.78 Billion
27,958,563 Added 32.84%
113,099,222 $6.78 Billion
Q4 2017

Feb 14, 2018
BUY
$53.68 - $57.47 $928 Million - $993 Million
17,279,533 Added 25.46%
85,140,659 $4.86 Billion
Q3 2017

Nov 14, 2017
BUY
$48.06 - $53.64 $3.26 Billion - $3.64 Billion
67,861,126
67,861,126 $3.62 Billion

Others Institutions Holding ABT

# of Institutions
3,377
Shares Held
1.33B
Call Options Held
10.6M
Put Options Held
8.72M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $232B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email